- Investing Ideas
- /
- Global High Growth Potential Companies
Global High Growth Potential Companies
Results
8541
0 new
Companies with a Future performance score of at least 3, ordered by Future performance score.
8,541 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
AXSM | US$89.64 | -6.5% | 28.3% | US$4.3b | US$125.24 | PS14.8x | E68.9% | n/a | Pharmaceuticals & Biotech | ||
NEWBRY | SEK 3.66 | 21.2% | 7.6% | SEK 88.8m | SEK 8.00 | PS4.8x | E116.2% | n/a | Pharmaceuticals & Biotech | ||
KEBNI B | SEK 1.22 | 6.1% | 2.7% | SEK 331.9m | SEK 2.20 | PS2.9x | E86.1% | n/a | Tech | ||
AGP | €6.98 | 3.6% | 63.5% | €120.8m | €12.75 | PE17.8x | E22.1% | n/a | Capital Goods | ||
TGTX | US$23.83 | -3.3% | 185.0% | US$3.3b | US$33.75 | PE35.7x | E43.5% | n/a | Pharmaceuticals & Biotech | ||
CALTX | SEK 206.20 | -0.1% | 111.5% | SEK 11.1b | SEK 227.50 | PS7x | E50.4% | n/a | Pharmaceuticals & Biotech | ||
ZVRA | US$6.92 | -14.1% | 43.6% | US$384.6m | US$20.50 | PS15.4x | E68.5% | n/a | Pharmaceuticals & Biotech | ||
ONON | US$51.13 | 2.4% | 83.8% | US$16.5b | US$50.05 | PE89.3x | E24.2% | n/a | Consumer Durables | ||
CADLR | NOK 72.60 | 2.7% | 99.3% | NOK 25.5b | NOK 81.94 | PS17.6x | E67.8% | n/a | Capital Goods | ||
ARES | US$156.91 | 0.2% | 52.5% | US$48.8b | US$150.23 | PE82.8x | E32.9% | 2.4% | Diversified Financials | ||
MBTN | CHF 1.73 | 11.9% | -99.4% | CHF 53.4m | CHF 6.03 | PB0.3x | E95.4% | n/a | Semiconductors | ||
SCOL | SEK 0.15 | 4.8% | -89.9% | SEK 35.5m | n/a | PB0.8x | E75.3% | n/a | Pharmaceuticals & Biotech | ||
AFISH | NOK 49.00 | 8.9% | -46.4% | NOK 1.6b | NOK 81.00 | PS1.6x | E98.9% | n/a | Food, Beverage & Tobacco | ||
CRDO | US$31.45 | 7.8% | 106.2% | US$5.2b | US$35.33 | PS24x | E95.0% | n/a | Semiconductors | ||
AESI | US$21.41 | -5.5% | -3.7% | US$2.3b | US$26.00 | PE16.1x | E42.1% | 4.3% | Energy | ||
GGP | UK£0.07 | 6.8% | 8.6% | UK£353.8m | n/a | PB7.1x | E48.8% | n/a | Materials | ||
FWRY | ج.م8.37 | -0.4% | 61.9% | ج.م28.5b | ج.م11.44 | PE29.6x | E29.4% | n/a | Diversified Financials | ||
RMDA | ج.م2.75 | 3.8% | 92.2% | ج.م4.1b | ج.م4.11 | PE18.2x | E30.2% | 2.4% | Pharmaceuticals & Biotech | ||
LAVV3 | R$8.00 | -3.5% | 6.0% | R$1.6b | R$12.98 | PE5.7x | E21.1% | 3.6% | Real Estate Management and Development | ||
EH | US$14.07 | 18.1% | -21.9% | US$876.5m | US$24.35 | PS25.1x | E81.4% | n/a | Capital Goods | ||
NVDA | US$121.40 | 4.7% | 179.1% | US$3.0t | US$14.99 | PE56.2x | E22.3% | 0.03% | Semiconductors | ||
SRPT | US$124.53 | -2.1% | 2.7% | US$11.9b | US$194.36 | PE251.1x | E44.1% | n/a | Pharmaceuticals & Biotech | ||
TVTX | US$14.01 | -7.9% | 56.7% | US$1.2b | US$16.71 | PS6x | E69.3% | n/a | Pharmaceuticals & Biotech | ||
MVW | NOK 10.30 | 1.0% | 22.6% | NOK 337.0m | NOK 12.20 | PS19.6x | E70.8% | n/a | Materials |